Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05DQR
|
|||
| Former ID |
DIB006223
|
|||
| Drug Name |
HDV-interferon
|
|||
| Synonyms |
HDV-interferon (sc, HCV infection); HDV-IFN (sc, HCV infection), Hepasome Pharmaceuticals; HDV-interferon (sc, HCV infection), Hepasome Pharmaceuticals
Click to Show/Hide
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Phase 2 | [1] | |
| Company |
Hepasome Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Interferon receptor (IFNR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00703872) HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients. U.S. National Institutes of Health. | |||
| REF 2 | Interferon in HDV infection. Antiviral Res. 1994 Jul;24(2-3):165-74. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.